LUMICKS

LUMICKS is a private, revenue-generating life science tools company specializing in high-end instrumentation for dynamic single-molecule and cell avidity analysis. Its core technology platforms, the C-Trap for single-molecule biophysics and the z-Movi for cell avidity measurement, enable real-time, functional analysis of biomolecular interactions, which is critical for drug discovery in areas like immuno-oncology. The company serves academic and biopharmaceutical clients globally, having raised significant venture funding to fuel its commercial expansion and technology development.

Two integrated platforms: 1) Dynamic Single-Molecule (C-Trap): combines optical tweezers, fluorescence, and microfluidics to manipulate and visualize individual biomolecules in real-time. 2) Cell Avidity (z-Movi): uses acoustic force spectroscopy to measure the combined binding strength (avidity) of cell-cell and cell-protein interactions.

In single-molecule analysis, competitors include Bruker (optical tweezers) and Refeyn (mass photometry). In cell analysis and immuno-oncology, it faces a broader array of companies offering flow cytometry, killing assays, and label-free biosensors (e.g., Sartorius, Agilent). LUMICKS' differentiation lies in the direct, real-time, and force-based measurement of interactions, a unique niche not fully addressed by incumbent technologies.